Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $.01 par value
-
Shares outstanding
-
4.41M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
270K
-
Shares change
-
-422K
-
Total reported value, excl. options
-
$846K
-
Value change
-
-$1.3M
-
Number of buys
-
2
-
Number of sells
-
-8
-
Price
-
$3.11
Significant Holders of INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value (IDXG) as of Q4 2020
15 filings reported holding IDXG - INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value as of Q4 2020.
INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value (IDXG) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 270K shares
of 4.41M outstanding shares and own 6.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (117K shares), VANGUARD GROUP INC (80.6K shares), GEODE CAPITAL MANAGEMENT, LLC (32.5K shares), Squarepoint Ops LLC (20.8K shares), DIMENSIONAL FUND ADVISORS LP (12.9K shares), UBS Group AG (2.95K shares), Tower Research Capital LLC (TRC) (1.93K shares), Allworth Financial LP (1.43K shares), Federation des caisses Desjardins du Quebec (1K shares), and American Portfolios Advisors (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.